
S100A1 Genetically Targeted Therapy Reverses Dysfunction of Human Failing Cardiomyocytes
Keywords: calcium; gene therapy; heart failure; S100A1; sarcoplasmic reticulumβ-AR, beta-adrenergic receptor; Ad, adenoviral; CaMKII, calmodulin-dependent protein kinase II; FFR, force-frequency response; FS, fractional shortening; HF, heart failure; HFCM, human fa